Antitumor efficacy of multi-target in situ vaccinations with CpG oligodeoxynucleotides, anti-OX40, anti-PD1 antibodies, and aptamers.
Proskurina AS, Ruzanova VS, Ritter GS, Efremov YR, Mustafin ZS, Lashin SA, Burakova EA, Fokina AA, Zatsepin TS, Stetsenko DA, Leplina OY, Ostanin AA, Chernykh ER, Bogachev SS.
Proskurina AS, et al. Among authors: fokina aa.
J Biomed Res. 2022 Nov 28;37(3):194-212. doi: 10.7555/JBR.36.20220052.
J Biomed Res. 2022.
PMID: 37161885
Free PMC article.